Amneal Pharmaceuticals, Inc. (AMRX)
12.75
-0.13
(-1.01%)
USD |
NASDAQ |
Dec 31, 10:57
Amneal Pharmaceuticals EPS Diluted (Quarterly): 0.0073 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Johnson & Johnson | 2.121 |
| Amgen, Inc. | 5.934 |
| Corcept Therapeutics, Inc. | 0.1621 |
| United Therapeutics Corp. | 7.161 |
| Xeris Biopharma Holdings, Inc. | 0.0035 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | 18.13M |
| Revenue (Quarterly) | 784.51M |
| Total Expenses (Quarterly) | 782.14M |
| Enterprise Value | 6.566B |
| Gross Profit Margin (Quarterly) | 34.92% |
| Profit Margin (Quarterly) | 2.31% |
| Earnings Yield | 0.11% |
| Operating Earnings Yield | 8.92% |
| Normalized Earnings Yield | 0.8431 |